Journal articleAntibodies (Basel)2024
A High-Affinity Monoclonal Antibody Against the Pancreatic Ductal Adenocarcinoma Target, Anterior Gradient-2 (AGR2/PDIA17).
- Journal
- Antibodies (Basel)
- Published
- 5 December 2024
- Citations
- 0
- Type
- Article
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try
Grants 6
- Defining the KRAS mutation specific interactions in pancreas cancer P20GM130457↗
- Cancer Biology and Immunology Program P30CA138313↗
- Inhibitors of Oxidative Protein Folding For The Treatment of Cancer R01CA245081↗
- Bispecific T cell engagers for the treatment of pancreatic ductal adenocarcinoma R41CA265624↗
- AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma R42CA268138↗
- AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma R44CA268138↗